Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis

American Journal of Transplantation

Volumn 11, Issue 11, 2011, Pages 2517-2522

  Diamond, J M ^a   Lederer, D J ^e   Kawut, S M ^a,b,c   Lee, J ^a   Ahya, V N ^a   Bellamy, S ^a   Palmer, S M ^g   Lama, V N ^h   Bhorade, S ⁱ   Crespo, M ^j   Demissie, E ^a,b   Sonett, J ^f   Wille, K ^k   Orens, J ^l   Shah, P D ^m   Weinacker, A ⁿ   Weill, D ⁿ   Kohl, B A ^d   Deutschman, C C ^d   Arcasoy, S ^e   Shah, A S ^o   Belperio, J A ^p   Wilkes, D ^q   Reynolds, J M ^q   Ware, L B ^m   Christie, J D ^a,b   more..

^a Pulmonary Allergy and Critical Care Division ^*  (United States)

^b Center for Clinical Epidemiology and Biostatistics   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Critical Care Medicine   (United States)

^f College of Physicians ^*  (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁿ STANFORD UNIVERSITY   (United States)

^o JOHNS HOPKINS HOSPITAL   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q INDIANA UNIVERSITY   (United States)

more..

Author keywords

Idiopathic pulmonary fibrosis; Long pentraxin 3; Lung transplantation; Primary graft dysfunction

Indexed keywords

PENTRAXIN 3;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG TRANSPLANTATION; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNITY, INNATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPERFUSION INJURY; SERUM AMYLOID P-COMPONENT;

EID: 84857193578     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03702.x     Document Type: Article

References (20)

1. Iwata T, Philipovskiy A, Fisher AJ, et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008; 181: 5738-5747.
2. Moreno I, Vicente R, Ramos F, Vicente JL, Barbera M. Determination of interleukin-6 in lung transplantation: Association with primary graft dysfunction. Transplant Proc 2007; 39: 2425-2426. (Pubitemid 47418206)
3. Diamond JM, Christie JD. The contribution of airway and lung tissue ischemia to primary graft dysfunction. Curr Opin Organ Transplant 2010; 15: 552-557.
4. Millington TM, Madsen JC. Innate immunity and cardiac allograft rejection. Kidney Int 2010; 78(Suppl 119): S18-S21.
5. Millington TM, Madsen JC. Innate immunity in heart transplantation. Curr Opin Organ Transplant 2009; 14: 571-576.
6. Kosieradzki M, Rowinski W. Ischemia/reperfusion injury in kidney transplantation: Mechanisms and prevention. Transplant Proc 2008; 40: 3279-3288.
7. Uchida Y, Ke B, Freitas MC, et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139: 2195-2206.
8. Hoffman SA, Wang L, Shah CV, et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009; 9: 389-396.
9. Peri G, Introna M, Corradi D, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000; 102: 636-641. (Pubitemid 30640663)
10. Han B, Haitsma JJ, Zhang Y, et al. Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury. Intensive CareMed 2011; 37: 334-342.
11. Mauri T, Coppadoro A, Bellani G, et al. Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity. Crit Care Med 2008; 36: 2302-2308.
12. Covarrubias M, Ware LB, Kawut SM, et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573-2578. (Pubitemid 47561623)
13. Christie JD, Bellamy S, Ware LB, et al. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29: 1231-1239.
14. Christie JD, Shah CV, Kawut SM, et al. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009; 180: 1010-1015.
15. Diamond JM, Kawut SM, Lederer DJ, et al. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant 2011; 11: 561-567.
16. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232-1241. (Pubitemid 37290031)
17. Kuntz CL, Hadjiliadis D, Ahya VN, et al. Risk factors for early primary graft dysfunction after lung transplantation: A registry study. Clin Transplant 2009; 23; 819-830.
18. Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001; 29: 1404-1407. (Pubitemid 32641804)
19. Ortega-Hernandez OD, Bassi N, Shoenfeld Y, Anaya JM. The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum 2009; 39: 38-54.
20. Weill D, Dey GC, Hicks RA, et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002; 21: 555-558. (Pubitemid 34451027)